Ecopipam reduces stuttering symptoms in proof-of-concept trial

Psychiatrists have tested the orally administered investigational medication ecopipam on adults who stutter in an open-label, uncontrolled clinical trial and found that it reduced their stuttering symptoms from the start of therapy after eight weeks of dosing. Positive results included increased speech fluency, faster reading completion, and shortened duration of stuttering events.

Leave a Reply

Your email address will not be published. Required fields are marked *